President Barack Obama's top aides met frequently with lobbyists and health care industry heavyweights as his administration pieced together a national health care overhaul, according to White House visitor records obtained by The Associated Press.

Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker credit ratings will be under pressure until early 2012 because they won't be able to fully replace revenue from best-sellers that go off-patent.

A UBS analyst said Wednesday that medical technology stocks are trading at attractive prices, and raised his ratings or price targets on nine of them.

The Dow pared its gains in the final hour of trading after banking analyst Meredith Whitney said the recent market rally is not rooted in fundamentals and the U.S. economy is likely to fall back into a recession next year.

Shares of Merck & Co. rose Monday as Wall Street brushed off the potential for a severe impact from a rival company's sponsored study that showed the cholesterol drug Niaspin is potentially more effective than Merck's Zetia.

Stocks opened higher Monday, building on two weeks of gains, as a weak dollar boosted commodity stocks and a government report showed retail sales rose in October.

Stocks opened higher Monday, building on two weeks of gains, as a weak dollar boosted commodity stocks and a government report showed retail sales rose in October.

Stock index futures are pointing to a higher open Monday after data showed that Japan's economy grew nearly twice as much as expected in the third quarter.

The results of a highly-anticipated head-to-head cholesterol drug study further calls into question the level of effectiveness of Merck's  blockbusters Zetia and Vytorin.

After a stunning and broad rebound, major indices many be range bound for awhile and the right managers could thrive with judicious stockpicking.

Stocks pared some of their earlier losses but were still lower as disappointing results from Bank of America and General Electric eclipsed strong results from big techs.

Stocks pared some of their earlier losses but were still lower as disappointing results from Bank of America and General Electric eclipsed strong results from big techs.

Stocks skidded at the open Friday as disappointing results from Bank of America and General Electric eclipsed strong results from big techs. They slid further — with the Dow down 100 points — after a report showed a surprise drop in consumer sentiment.

Futures indicated a lower open for Wall Street Friday, as mixed earnings from General Electric eclipsed strong results from big techs.

The Dow pulled off a nearly 50-point  gain Thursday after a topsy-turvy session as the boost from oil's rally ultimately beat out disappointment in earnings from Goldman Sachs and Citigroup.